| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 11/19/2003 | CN1456662A Barm expressing system of plasminogen and purifying process |
| 11/19/2003 | CN1128364C Light microscope detection technology for blood and lymph of shrimp and crab |
| 11/19/2003 | CN1128226C PCR/RFLP molecular assay method for Chinese and Hepu eriocheir sinensises and its reagent kit |
| 11/18/2003 | US6651010 Vector-based method for visualizing secondary structure of RNA molecules |
| 11/18/2003 | US6650414 Method of monitoring microbe in water |
| 11/18/2003 | US6649769 For labelling a polynucleotides |
| 11/18/2003 | US6649751 Reacting biopolymers with alkylamines and ammonium hydroxide, heating and eluting through columns having ion exchange resins, then recovering the polynuleotides; solid phase synthesis |
| 11/18/2003 | US6649749 Oligonuclelotide mix for use in the detection and treatment of viral diseases |
| 11/18/2003 | US6649744 Rnase P polypeptides, polynucleotides, and methods using their mechanisms of action |
| 11/18/2003 | US6649743 Monoclonal antibody against estrogen stimulated leucine aminopeptidase |
| 11/18/2003 | US6649741 Tumor antigen-derived gene (TADG) of given sequence; detecting binding of antibody to the protein; useful in diagnosis, treatment and prevention; breast and ovarian |
| 11/18/2003 | US6649737 Human galactosyltranferases |
| 11/18/2003 | US6649598 4,7-dichlorofluorescein dyes as molecular probes |
| 11/18/2003 | US6649588 Using ebaf protein from amino acid sequence 2 |
| 11/18/2003 | US6649573 Comprising 25%-70% by volume polymeric carrier, 5%-75% by volume lubricant powder, 0%-20% by volume synthetic extreme pressure anti-wear liquid oil, 0-1% by volume optical brightener; for railway wheels |
| 11/18/2003 | US6649414 Carriers; polymeric; staining with dyes; useful for multiplexed analysis of a plurality of analytes in a sample |
| 11/18/2003 | US6649411 Also using ADNF III nucleic acid probes to detect the presence of pathologically proliferating cells in human tissues. |
| 11/18/2003 | US6649410 Method for the development of an HIV vaccine |
| 11/18/2003 | US6649404 Detecting binding between a immobilized and mobile chemical species (oligonucleotides); signals; use in diagnosis and gene/drug discovery |
| 11/18/2003 | US6649394 Topoisomerase IV, corresponding nucleotide sequences and uses thereof |
| 11/18/2003 | US6649391 Isolated polynucleotide encoding a polypeptide of given sequence; dephosphorylates MAP(mitogen activated protein)-kinase; used for modulating cell proliferation, differentiation and survival |
| 11/18/2003 | US6649389 Peptide for use in the diagnosis and treatment of cancer, thyroid, diabetes, atherosclerosis, and cardiovascular disorders |
| 11/18/2003 | US6649388 Polypeptides derived from JNK3 |
| 11/18/2003 | US6649378 Self-contained device integrating nucleic acid extraction, amplification and detection |
| 11/18/2003 | US6649370 Isolated polynucleotide which induces a immune response when administered to a mammal; expression vectors; vaccines |
| 11/18/2003 | US6649365 Tracer agent, of given formula, comprising acyl residue of an amino acid or a peptide; fluorescence; colorimetric analysis; use in identifying microorganisms |
| 11/18/2003 | US6649364 Anti-apoptotic compositions and methods using same |
| 11/18/2003 | US6649362 Administering an agent to modulate sphingosine kinase signalling pathway to treat coronary heart disease |
| 11/18/2003 | US6649359 Diagnosis of endometrial precancers |
| 11/18/2003 | US6649357 Apparatus and method for detecting and identifying infectious agents |
| 11/18/2003 | US6649356 Apparatus for use in the detection of infections in humans |
| 11/18/2003 | US6649354 Catalytically generated mass labels |
| 11/18/2003 | US6649350 Electrochemical sensor using intercalative, redox-active moieties |
| 11/18/2003 | US6649349 Peptide nucleic acid for use in the diagnosis, detection and prevention of blood, respiratory and cancer disorders |
| 11/18/2003 | US6649347 Use of methylated nucleic acid segments for isolating centromere DNA |
| 11/18/2003 | US6649345 Phenylalanine hydroxylase gene variants, and amino acid and pterin homeostasis, in the definition, detection, treatment and prevention of psychotic, mood and personality disorders |
| 11/18/2003 | US6649343 DNA chip and method for producing the same |
| 11/18/2003 | US6649341 Detection of cancerous lymphocytes by isolating mRNA, hybridizing a probe specific for given nucleotide sequence and determining presence of transcript product; use in diagnosis/treatment of leukemia; hormone therapy |
| 11/18/2003 | US6649339 Screening for the presence of a parvovirus genome equivalent using nucleic acid amplification; purification |
| 11/18/2003 | US6649198 Process for producing bread |
| 11/18/2003 | US6649164 (RANK); RANK is a member of the TNF superfamily; used to regulate an immune response |
| 11/18/2003 | US6649159 Monitoring preferential gene expression of a gene; transfering nucleotide sequences to cells, incubate, monitor intensity of fluoresence |
| 11/18/2003 | US6649143 Non-invasive localization of a light-emitting conjugate in a mammal |
| 11/18/2003 | CA2143845C Self-assembling recombinant papillomavirus capsid proteins |
| 11/13/2003 | WO2003094088A1 Mouse olfactory receptor gene superfamily specification |
| 11/13/2003 | WO2003093831A1 Diagnostic test for determining the concentration of transient proteolytic activity in composite biological media |
| 11/13/2003 | WO2003093797A2 Polynucleotides for the detection and quantification of hepatitis b virus nucleic acids |
| 11/13/2003 | WO2003093795A2 Device and method for analytical cell imaging |
| 11/13/2003 | WO2003093794A2 Methods for discovering tumor biomarkers and diagnosing tumors |
| 11/13/2003 | WO2003093793A2 Binary or polynary targeting and uses thereof |
| 11/13/2003 | WO2003093790A2 Sensors for biomolecular detection and cell classification |
| 11/13/2003 | WO2003093789A2 Method for measuring ion channel activity |
| 11/13/2003 | WO2003093788A2 Test strip and method for determining concentration of creatinine in a body fluid |
| 11/13/2003 | WO2003093786A2 Short enzyme donor fragment |
| 11/13/2003 | WO2003093510A1 Compositions and methods relating to colon specific genes and proteins |
| 11/13/2003 | WO2003093509A1 Methods and compositions for improving specificity of pcr amplication |
| 11/13/2003 | WO2003093508A1 Method of detecting rheumatoid arthritis by detecting overexpression of wnt |
| 11/13/2003 | WO2003093507A1 Nucleic acids and methods for determining susceptibility to wilms' tumor |
| 11/13/2003 | WO2003093506A2 Mitochondrial polymorphisms linked to a predisposition for the development of inappropriate scarring or fibrosis |
| 11/13/2003 | WO2003093505A2 Method for determining the presence of an unconventional transmissible agent responsible for transmissible subacute spongiform encephalopathy |
| 11/13/2003 | WO2003093504A1 Method for amplifying nucleic acids |
| 11/13/2003 | WO2003093503A2 Method for bioequivalence determination using expression profiling |
| 11/13/2003 | WO2003093502A2 Multiplexed determination of nucleic acid polymorphisms |
| 11/13/2003 | WO2003093501A2 Ssh based methods for identifying and isolating unique nucleic acid sequences |
| 11/13/2003 | WO2003093500A1 Optimisation of primer libraries by extension of short primers |
| 11/13/2003 | WO2003093499A2 Therapeutic use of selective pde10 inhibitors |
| 11/13/2003 | WO2003093498A1 Inhibition of protein tyrosine phosphatases and sh2 domains by a neutral phosphotyrosine mimetic |
| 11/13/2003 | WO2003093497A1 Means and methods for detecting endoglycosidase activity |
| 11/13/2003 | WO2003093495A2 Diffraction-based diagnostic devices |
| 11/13/2003 | WO2003093494A2 Apparatus including ion transport detecting structures and methods of use |
| 11/13/2003 | WO2003093492A2 Compositions and methods for determining susceptibility of hepatitis c virus to anti-viral drugs |
| 11/13/2003 | WO2003093460A1 Method for direct rescue and amplification of integrated viruses from cellular dna of tissues |
| 11/13/2003 | WO2003093452A2 Variants of nedd4l associated with hypertension and viral budding |
| 11/13/2003 | WO2003093445A2 Method for predicting gene potential and cell commitment |
| 11/13/2003 | WO2003093438A2 Human adipocyte cell populations and methods for identifying modulators of same |
| 11/13/2003 | WO2003093432A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 11/13/2003 | WO2003093429A2 Nucleic acid reactions using labels with different redox potentials |
| 11/13/2003 | WO2003093422A2 Novel tissue factor targeted antibodies as anticoagulants |
| 11/13/2003 | WO2003093414A2 Transgenic animal model for spliceosome-mediated rna trans-splicing |
| 11/13/2003 | WO2003093411A2 Ice1, a regulator of cold induced transcriptome and freezing tolerance in plants |
| 11/13/2003 | WO2003093407A1 Device for the amplification of dna, comprising a microwave energy source |
| 11/13/2003 | WO2003093406A2 Microfermentors for rapid screening and analysis of biochemical processes |
| 11/13/2003 | WO2003093311A1 Proteins with deglycating activities and methods of using same |
| 11/13/2003 | WO2003092740A1 Non-viral gene delivery system |
| 11/13/2003 | WO2003092739A1 Non-viral gene delivery system |
| 11/13/2003 | WO2003092715A2 Proteins involved in the regulation of energy homeostasis |
| 11/13/2003 | WO2003092705A1 Diagnosis and treatment of glaucoma and methods for discovering new glaucoma therapeutic agents based on the wnt/ca2+ signaling pathway |
| 11/13/2003 | WO2003092627A2 High throughput screening assay for detecting a dna sequence |
| 11/13/2003 | WO2003092616A2 Therapeutic compositions comprised of pentamidine and methods of using same to treat cancer |
| 11/13/2003 | WO2003092602A2 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants |
| 11/13/2003 | WO2003092582A2 Chimeric ebola virus envelopes and uses therefor |
| 11/13/2003 | WO2003092581A2 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| 11/13/2003 | WO2003092475A2 Diagnosis and treatment of glaucoma |
| 11/13/2003 | WO2003092467A2 Compositions and methods relating to abca1-mediated cholesterol efflux |
| 11/13/2003 | WO2003092370A1 Human chronic lymphocytic leukemia modeled in mouse by targeted tcl1 expression |
| 11/13/2003 | WO2003072739A3 Trans-splicing mediated imaging of gene expression |
| 11/13/2003 | WO2003072090A3 Use of tyrosine kinase inhibitors for treating cns disorders |
| 11/13/2003 | WO2003068968A3 Mutated gene coding for a lat protein and the biological applications thereof |
| 11/13/2003 | WO2003064700A3 Identification of cell differentiation states based on methylation patterns |
| 11/13/2003 | WO2003064689A3 Methods for identifying polyadenylation sites and genes thereof |